Status:

COMPLETED

Sphenopalatine Ganglion Block in Septorhinoplasty

Lead Sponsor:

Istanbul Medeniyet University

Conditions:

Pain, Postoperative

Rhinoplasty

Eligibility:

All Genders

18-65 years

Brief Summary

Septorhinoplasty is a widely performed surgery that aims to correct both functional and aesthetic problems of the nose. Despite its expected clinical benefits, septorhinoplasty surgery causes postoper...

Eligibility Criteria

Inclusion

  • Undergoing septorhinoplasty surgery
  • Ages between 18-65
  • ASA (American Society of Anesthesiologists) score I-II

Exclusion

  • Unavailable postoperative pain scores and analgesic use in the hospital registry system
  • Local anesthetic drug allergy and toxicity
  • Advanced organ failure
  • Mental retardation
  • Patients who are pregnant

Key Trial Info

Start Date :

June 7 2023

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 21 2023

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT06157970

Start Date

June 7 2023

End Date

August 21 2023

Last Update

December 6 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Suheda Akbulut

Istanbul, Turkey (Türkiye)

Sphenopalatine Ganglion Block in Septorhinoplasty | DecenTrialz